Finally, we show that metformin modulated master cancer metabolic modulators such as c-MYC and IRS2 in the ALDHbright cells and this correlated with modulation of the microRNA-33a which is known to target both the abovementioned factors. The gene discussed is MYC; the disease is cancer.